Working… Menu

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02044250
Recruitment Status : Completed
First Posted : January 23, 2014
Last Update Posted : April 14, 2021
Chong Kun Dang Pharmaceutical
Samjin Pharmaceutical Co., Ltd.
Daewoong Pharmaceutical Co. LTD.
Hanmi Pharmaceutical co., ltd.
Information provided by (Responsible Party):
Hyo-Soo Kim, Seoul National University Hospital